1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Hematologic Disorder: new trials by email Literature Review of Hematologic Disorder trials Research Report on Hematologic Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL) Lenalidomide, Influenza Vaccine, Pneumovax Vaccine - Hematologic Disorder | Phase 2 | Terminated | M.D. Anderson Cancer Center | 3 | 2014-11-24 | 2018-09-20 |
Agammaglobulinemia (1) · Hematologic Diseases (1) · Influenza, Human (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1)
Blood Protein Disorders (1) · Chronic Disease (1) · Disease Attributes (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Immunoproliferative Disorders (1) · Infections (1) · Leukemia (1) · Leukemia, B-Cell (1) · Leukemia, Lymphoid (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Influenza Vaccines (1) · Lenalidomide (1) · SARS-CoV-2 inactivated vaccines (1)
M.D. Anderson Cancer Center (1)
United States (1)